Hospital doctors employed in France under the Praticien Hospitalier (PH) status have a published gross annual salary scale ranging from €55,607.79 to €112,416.56, depending on seniority and salary step. The current PH remuneration framework uses 13 salary steps, or échelons, with pay increasing as a physician progresses through the public hospital career structure. The official scale is set out in the national remuneration order for medical staff working in public health establishments. For physicians comparing hospital compensation in France, the most important point is that these figures represent gross hospital emoluments before additional allowances and payments. They are therefore a base remuneration benchmark rather than a complete measure of total annual earnings. What is the salary for a Praticien Hospitalier in France? The official PH salary scale runs from: €55,607.79 gross per year at échelon 1 to: €112,416.56 gross per year at échelon 13. The full published scale is: PH salary step Gross annual hospital emoluments Échelon 1 €55,607.79 Échelon 2 €58,082.41 Échelon 3 €62,148.07 Échelon 4 €66,567.09 Échelon 5 €68,688.21 Échelon 6 €71,162.83 Échelon 7 €76,465.74 Échelon 8 €79,647.54 Échelon 9 €90,549.14 Échelon 10 €94,557.64 Échelon 11 €99,810.26 Échelon 12 €105,062.89 Échelon 13 €112,416.56 These amounts are the official annual gross hospital emoluments for PHs. What does this mean in monthly terms? On a simple annual ÷12 basis, the scale equates approximately to: €4,634 per month at échelon 1 €9,368 per month at échelon 13 These monthly figures are useful for comparison, but the official French source publishes the PH scale as annual gross remuneration, not as a monthly salary table. How much does experience affect PH pay? A great deal. Progression from the first to the final PH step increases published annual gross hospital remuneration from: €55,607.79 to: €112,416.56 That is a difference of more than €56,800 per year across the career scale. For hospital doctors in France, seniority and progression through the échelons are therefore central to understanding base remuneration. The relevant question is not simply: “What does a hospital doctor earn in France?” It is also: “Which PH échelon applies to my current career stage?” Is this the total amount a Praticien Hospitalier earns? Not necessarily. The published PH scale represents hospital emoluments, but public-hospital doctors can also qualify for additional payments depending on their role and working arrangements. One of the most important is the: Indemnité d'engagement de service public exclusif The official remuneration order sets this allowance at: €1,010 per month for eligible physicians who commit to exclusive public service. On a 12-month basis, that could add: €12,120 gross per year to a physician's remuneration where the conditions are met. This means that a PH on the standard salary scale may receive significantly more than the base hospital emoluments alone. What is the prime d'exercice territorial? The official remuneration framework also provides a prime d'exercice territorial for eligible doctors working across sites. The monthly gross amounts are: €250 for one half-day per week outside the principal site €450 for more than one and up to three half-days €700 for more than three and up to four half-days €1,000 for four half-days across at least two additional sites, or more than four half-days These payments sit on top of the core PH remuneration where the relevant conditions are met. Are on-call and night duties included in the PH salary scale? No. The core salary scale should not be treated as a measure of all compensation associated with hospital work. Hospital physicians may receive additional remuneration for activities such as: permanence des soins; nights; weekends; public holidays; additional working time; and specific organisational responsibilities. These components can materially increase annual gross income beyond the published PH scale. For compensation comparisons, that distinction is crucial. A French PH base salary should not be directly compared with another country's physician-income survey if that survey includes overtime, on-call work, private activity or other additional earnings. Does specialty affect the PH salary scale? The PH scale itself is not specialty-specific. A cardiologist, neurologist, oncologist, radiologist or other specialist working under PH status is paid according to the relevant PH career scale rather than a separate nationally published salary table for each specialty. The data should therefore be interpreted as a benchmark for: public-hospital specialist physicians employed as Praticiens Hospitaliers rather than as evidence of what an individual specialty earns. That distinction matters for specialty-led compensation analysis. If we want to answer: “What do cardiologists earn in France?” we need cardiology-specific evidence. The PH scale instead answers: “What is the base public-hospital remuneration structure for specialist doctors employed under PH status in France?” How does this differ from private-practice physician income? It is a completely different type of compensation evidence. The PH scale applies to physicians employed within the public hospital system. Private-practice doctors may derive income from: consultations; procedures; reimbursement tariffs; private billing arrangements; and practice activity. Those figures should not be mixed with the PH salary scale. For example, Ameli consultation tariffs are reimbursement amounts per consultation or act, whereas the PH scale is employment remuneration. Likewise, CARMF income data reflects independent-practice professional income rather than public-hospital salary. Each dataset answers a different question. What should hospital doctors in France take from the 2026 salary data? For Praticiens Hospitaliers, the current official remuneration framework provides a clear base-pay benchmark. Gross annual hospital emoluments range from: €55,607.79 at échelon 1 to: €112,416.56 at échelon 13. Eligible physicians may then receive additional compensation such as: €1,010 per month for the exclusive public-service commitment allowance and up to: €1,000 per month in territorial-practice allowance depending on eligibility and working arrangements. The most useful question for an individual hospital doctor is therefore not simply: “What is the salary of a hospital doctor in France?” It is: “Which PH échelon applies to me, and which allowances and additional payments sit on top of my base hospital remuneration?” That provides a much more accurate picture of physician compensation within the French public hospital system. Source: Official French public-hospital medical remuneration scale under the Arrêté du 29 juin 2023 modifying the Arrêté du 8 juillet 2022, Annex II — Praticiens Hospitaliers. The official scale remains published by Légifrance. Discover how nuaxia can support your next medical education initiative: Find out more about our specialist services - Moore's Outcome Assessments, Educational Needs Assessments and Patient Impact Studies for the Medical Education sector Contact us on: support@nuaxia.com

Specialist doctors working in Spain’s public health system can see a substantial difference in their gross monthly pay depending on the autonomous community in which they work. The latest 2026 remuneration data for Facultativos Especialistas de Área (FEA) — hospital specialist physicians — shows ordinary gross monthly compensation ranging from approximately €3,066 to €4,813, before seniority payments and on-call duties are added. That creates a difference of more than €1,700 per month between regional health services. For hospital specialists in Spain, this is an important point: while parts of the public-sector salary structure are nationally standardised, regional supplements mean that the amount appearing on a specialist physician's payslip can vary considerably depending on where they work. What does a specialist doctor earn in Spain in 2026? According to the 2026 regional salary analysis, the ordinary gross monthly remuneration for an FEA without seniority payments or on-call duties is: Autonomous community Health service Gross monthly FEA pay Basque Country Osakidetza €4,813 Valencian Community Sanitat €4,206 Balearic Islands IB-Salut €4,202 La Rioja SERIS €4,135 Aragón SALUD €4,083 Madrid SERMAS €4,027 Ceuta & Melilla INGESA €4,008 Andalucía SAS €4,000 Canary Islands SCS €3,973 Cantabria SCS €3,789 Catalonia ICS €3,648 Asturias SESPA €3,624 Navarra SNS-O €3,501 Galicia SERGAS €3,345 Castilla y León SACYL €3,172 Castilla-La Mancha SESCAM €3,128 Murcia SMS €3,066 These figures refer to an ordinary month's gross remuneration, without trienios for seniority and without guardias. They should therefore be treated as a benchmark for fixed monthly public-sector compensation rather than a measure of a specialist's complete annual earnings. Why does specialist doctor pay vary so much across Spain? Spain's public-sector physician salary is made up of several components. For an FEA, the common elements include: Base A1 salary: €1,387.24 per month Destination supplement: €729.14 per month for level 24 Seniority payment: €53.39 per month for each three-year period of service Specific and productivity supplements: approximately €950 to €3,400 per month depending on the regional health service On-call payments: paid separately and set regionally The nationally determined base components therefore tell only part of the compensation story. The major differences arise from the complemento específico, productivity payments and other remuneration determined by each autonomous community. For a specialist doctor considering compensation in Spain, location can consequently make a meaningful difference even when the underlying clinical grade is similar. What does an FEA mean in Spain? FEA stands for Facultativo Especialista de Área. In practical terms, it refers to a specialist physician working within the hospital-based public health system. The category can include doctors working across specialties such as: cardiology; oncology; neurology; radiology; gastroenterology; pulmonology; dermatology; and other hospital specialties. However, the 2026 remuneration data does not provide separate salary scales for these individual specialties. It should therefore not be interpreted as showing a specific salary for a cardiologist, oncologist or neurologist. The figures provide a compensation benchmark for the FEA employment category. For an individual specialist, clinical specialty may influence workload, working patterns and opportunities for additional remuneration, but the regional salary figures themselves are not specialty-specific. How much does a specialist doctor earn in the Basque Country? The 2026 data shows an ordinary gross monthly FEA remuneration figure of approximately: €4,813 per month for the Basque Country. Official 2026 Osakidetza remuneration documentation separately confirms that the annual remuneration framework for a standard Facultativo position is €45,875.43, before considering every possible additional payment or individual circumstance. This illustrates an important methodological point: monthly salary comparisons and annual public-sector remuneration tables do not always describe exactly the same components. Physicians should therefore examine the individual elements included in any figure before making direct comparisons. How much does an FEA earn in Madrid? For Madrid, the ordinary gross monthly FEA figure in the regional comparison is approximately: €4,027 per month before seniority and guardias. But that figure does not tell the whole compensation story. On-call work can add substantially to a hospital specialist's earnings. From August 2026, the Community of Madrid increased physician guardia payments to: €484.31 for a standard working-day guardia €748.57 for a guardia performed on a public holiday with further increases scheduled for 2027. This demonstrates why two specialists with the same underlying FEA salary can ultimately receive very different total annual compensation depending on their working patterns. How important are guardias to specialist physician earnings? Very important. On-call work — guardias — is generally paid in addition to the ordinary monthly remuneration. The 2026 analysis estimates that guardias can contribute approximately: €12,000 to €24,000 in additional gross income per year depending on the number performed and the rates applied by the relevant autonomous community. This means that an FEA's headline monthly salary should not automatically be interpreted as their total earning potential. A specialist undertaking frequent nights, weekends and public-holiday guardias may have substantially higher gross annual earnings than another specialist on the same fixed remuneration but with fewer additional duties. What other payments can increase a specialist doctor's income? Beyond ordinary salary and guardias, several other components can affect remuneration. Seniority — trienios Doctors receive an additional payment for completed periods of service. The 2026 national A1 figure cited for a three-year period is approximately: €53.39 per month for each trienio. A physician with a longer public-sector career may therefore receive more than a newly appointed specialist. Professional career progression Many regional health systems also operate carrera profesional systems recognising experience, training and professional development. The amounts differ by autonomous community and career level. According to the 2026 analysis, these supplements can range from roughly €130 per month at lower stages to considerably higher amounts at advanced career levels in some regions. Exclusivity or dedication supplements Some health services also offer remuneration connected with exclusive dedication to the public system or incompatibility with private practice. Again, these arrangements differ significantly between regions. Is €3,066–€4,813 the total monthly income of a specialist doctor? Not necessarily. The clearest interpretation of these figures is: They represent ordinary gross monthly FEA remuneration before seniority and guardia payments. A specialist's actual compensation may include: base salary; destination supplement; specific supplement; productivity payments; seniority; professional career payments; guardias; nights and public-holiday payments; and other regional supplements. This distinction is essential when comparing physician salaries. A €4,000 ordinary monthly figure should not be compared directly with another dataset reporting total annual earnings including extensive on-call work. Why is the region so important for specialist doctors in Spain? Spain operates a decentralised health system. Although some salary components are nationally defined, autonomous communities administer their own health services and determine important additional remuneration. The result is that two hospital specialists employed within the Spanish public health system can have materially different fixed compensation depending on where they work. According to the 2026 figures, the difference between the highest and lowest ordinary FEA monthly remuneration is approximately: €1,747 per month. For specialists evaluating a role, salary comparisons should therefore consider the regional health service rather than relying on a single "Spanish doctor salary". Does this tell us what cardiologists or oncologists earn? Not specifically. This dataset is useful because it provides a current benchmark for hospital specialist physicians as an employment group. It does not provide separate compensation figures for cardiology, oncology, radiology, neurology or other individual specialties. A cardiologist working as an FEA should therefore use the relevant regional FEA figure as a public-sector employment benchmark — not as evidence of a cardiology-specific national salary. The same applies to other hospital specialties. Specialty-specific compensation analysis requires specialty-specific evidence. What should specialist doctors in Spain take from the 2026 data? For hospital specialists working in Spain's public health system, the most important finding is that there is no single FEA salary that accurately describes compensation throughout the country. Ordinary gross monthly FEA remuneration in the latest 2026 data ranges from approximately: €3,066 to €4,813 per month before seniority and guardias are included. Additional duties can then have a major effect on total remuneration, particularly guardias. For an individual specialist physician, the more useful question is therefore not simply: “How much does a specialist doctor earn in Spain?” It is: “What is the fixed FEA remuneration in my autonomous community, and how much do seniority, career progression and guardias add to my total compensation?” That provides a much more meaningful benchmark for understanding specialist physician pay in Spain. Sources: 2026 regional physician remuneration tables compiled by CalculadorNomina.es from national and autonomous-community salary documentation, including SERMAS, ICS, SAS, Osakidetza, SERGAS and other regional health services. The comparison was published on 23 July 2026. Official 2026 remuneration documentation from Osakidetza and the Community of Madrid was also reviewed as supporting evidence. Discover how nuaxia can support your next medical education initiative: Find out more about our specialist services - Moore's Outcome Assessments, Educational Needs Assessments and Patient Impact Studies for the Medical Education sector Contact us on: support@nuaxia.com

Cardiff Oncology and Nerviano have resolved their licensing dispute and amended the global onvansertib licence agreement, updating exclusivity, economics and termination provisions. The companies have settled litigation relating to Cardiff's rights to onvansertib and revised the terms of their 2017 exclusive worldwide licence agreement without either party making a settlement payment. The amended agreement provides a clearer commercial framework for continued development of onvansertib, Cardiff's PLK1 inhibitor being evaluated across multiple oncology indications. Field Content Alert Type Deal Companies Cardiff Oncology; Nerviano Medical Sciences Deal Type Licence amendment and dispute settlement Asset or Company Onvansertib Therapy Area(s) Oncology Technology or Modality PLK1 inhibitor; small-molecule targeted therapy Deal Value No settlement payment; revised licence economics and contractual terms Geography Worldwide What Happened Cardiff Oncology and Nerviano resolved litigation over the global rights to onvansertib and amended their 2017 exclusive worldwide licence agreement. Why It Matters The settlement removes legal uncertainty around Cardiff's principal oncology asset and establishes updated commercial and contractual terms for its continued development. Supporting Context Onvansertib is an oral small-molecule inhibitor of polo-like kinase 1, or PLK1, being developed by Cardiff Oncology in multiple cancer settings. Strategic Rationale The revised agreement gives both companies greater clarity around exclusivity, economics and termination rights while allowing Cardiff to continue advancing onvansertib. Potential Impact Resolution of the dispute reduces a potential development and financing overhang for Cardiff's oncology pipeline. Key Takeaway Cardiff Oncology and Nerviano have settled their onvansertib licensing dispute and agreed revised terms governing the global programme. What to Watch Further clinical development of onvansertib and the practical impact of the revised licence economics on Cardiff's commercial strategy. Primary Source Cardiff Oncology Relevant Date 11 September 2026 Discover how nuaxia can support your next medical education initiative: Find out more about our specialist services - Moore's Outcome Assessments, Educational Needs Assessments and Patient Impact Studies for the Medical Education sector Contact us on: support@nuaxia.com

Proteomics International has begun the controlled commercial rollout of its PromarkerD and PromarkerEso blood tests in Western Australia and the Northern Territory through its exclusive pathology distribution agreement with Healius. The rollout expands clinical access to PromarkerD, which assesses diabetic kidney disease risk, and PromarkerEso, which supports detection of oesophageal adenocarcinoma, ahead of a planned broader national launch. The commercial milestone moves both tests further into routine pathology channels and represents an important step in Proteomics International's strategy to scale its diagnostic portfolio across Australia. Field Content Alert Type Industry Update Companies Proteomics International; Healius Development Type Commercial rollout Products PromarkerD; PromarkerEso Therapy Area(s) Diabetes; kidney disease; oncology; oesophageal cancer Technology or Modality Blood-based proteomic diagnostic tests Geography Western Australia; Northern Territory; Australia What Happened Proteomics International began the controlled market release of PromarkerD and PromarkerEso through Healius pathology services in Western Australia and the Northern Territory. Why It Matters The rollout moves the tests from development and validation into broader clinical use through a major pathology network and provides a pathway toward national commercialisation. Supporting Context PromarkerD is designed to assess risk of diabetic kidney disease progression, while PromarkerEso is a blood test intended to support detection of oesophageal adenocarcinoma. Strategic Rationale The Healius distribution agreement gives Proteomics International access to established pathology infrastructure and a scalable channel for introducing its diagnostic products to clinicians and patients. Potential Impact Wider clinical access could support earlier risk identification and diagnosis while generating real-world commercial and clinical evidence for both tests. Key Takeaway Proteomics International has started commercial deployment of PromarkerD and PromarkerEso in WA and the NT through Healius ahead of a planned national rollout. What to Watch Expansion into additional Australian states, clinician adoption and progress toward full national availability. Primary Source Proteomics International Relevant Date 14 September 2026 Discover how nuaxia can support your next medical education initiative: Find out more about our specialist services - Moore's Outcome Assessments, Educational Needs Assessments and Patient Impact Studies for the Medical Education sector Contact us on: support@nuaxia.com

Jaguar LAA has acquired assets from Johnson & Johnson related to the Laminar left atrial appendage closure programme, creating a newly independent medical-device company focused on advancing the technology. The transaction transfers the Laminar programme and associated assets to Jaguar LAA, which has also brought key programme personnel into the new organisation to continue development of the left atrial appendage closure platform. Jaguar LAA plans to advance the programme through additional development and regulatory activity, positioning the company to continue work on a potential device-based approach to reducing stroke risk in patients with atrial fibrillation. Field Content Alert Type Deal Companies Jaguar LAA; Johnson & Johnson Deal Type Asset acquisition Asset or Company Laminar left atrial appendage closure programme Therapy Area(s) Cardiology; atrial fibrillation; structural heart Technology or Modality Left atrial appendage closure medical device Deal Value Financial terms were not disclosed Geography United States What Happened Jaguar LAA acquired Johnson & Johnson assets related to the Laminar left atrial appendage closure programme and brought key programme personnel into the newly formed independent company. Why It Matters The transaction preserves development of the Laminar technology outside Johnson & Johnson and creates a dedicated organisation focused on advancing the programme toward further regulatory and commercial milestones. Supporting Context Left atrial appendage closure devices are designed to reduce stroke risk in selected patients with atrial fibrillation by isolating the appendage, where blood clots can form. Strategic Rationale Jaguar LAA gains control of an established medtech programme, intellectual property and experienced personnel while creating a focused development organisation around the Laminar platform. Potential Impact Successful development and regulatory approval could add another device-based option for stroke prevention in patients with atrial fibrillation. Key Takeaway Jaguar LAA has acquired the Laminar left atrial appendage closure assets from Johnson & Johnson and will continue development of the programme independently. What to Watch Future clinical development, regulatory submissions and financing milestones for the Laminar programme. Primary Source PR Newswire Relevant Date 11 September 2026 Discover how nuaxia can support your next medical education initiative: Find out more about our specialist services - Moore's Outcome Assessments, Educational Needs Assessments and Patient Impact Studies for the Medical Education sector Contact us on: support@nuaxia.com

Doctors working in Germany’s municipal hospitals can earn between €5,722 and €11,923 gross per month under the latest TV-Ärzte/VKA collective agreement, depending on their level of seniority and experience. The current salary table applies from 1 June 2026 to 31 December 2026 and covers full-time doctors working a 40-hour week in municipal hospitals across Germany, excluding Berlin. For specialist physicians, or Fachärzte, the current tariff salary ranges from: €7,552 per month to €9,699 per month That is equivalent to approximately: €90,626 to €116,387 per year in base salary For senior physicians, or Oberärzte, the salary scale rises further, reaching approximately €129,731 per year at the highest published tariff stage. These figures are particularly useful because they provide a current 2026 benchmark for salaried doctors working in Germany's municipal hospital system. However, they represent tariff base salary, not necessarily total annual physician earnings. What is the 2026 salary for hospital doctors in Germany? The TV-Ärzte/VKA agreement divides doctors into four principal salary groups. Arzt / Ärztin Doctors in the Ä1 category earn between: €5,722.05 and €7,355.29 gross per month depending on their years of medical employment. On a simple 12-month basis, this equates to approximately: ~ €68,665 to €88,263 gross per year The six stages are: Experience Monthly base salary Approx. annual base salary 1st year €5,722.05 €68,665 2nd year €6,046.42 €72,557 3rd year €6,278.07 €75,337 4th year €6,679.58 €80,155 5th year €7,158.37 €85,900 6th year €7,355.29 €88,263 How much do specialist doctors — Fachärzte — earn in Germany? For doctors who have completed specialist training and are employed as a Facharzt or Fachärztin, the 2026 tariff begins at: €7,552.19 gross per month and reaches: €9,698.91 gross per month at the highest published experience stage. That gives the following base-salary range: Specialist experience Monthly base salary Approx. annual base salary From 1st year €7,552.19 €90,626 From 4th year €8,185.40 €98,225 From 7th year €8,741.40 €104,897 From 9th year €9,065.74 €108,789 From 11th year €9,382.33 €112,588 From 13th year €9,698.91 €116,387 For a specialist physician working in a municipal hospital, this is one of the clearest current salary benchmarks available in Germany. A newly qualifying Facharzt entering the first tariff stage therefore has a base salary of approximately €90,600 a year, while a doctor who has progressed to the highest published Facharzt stage receives approximately €116,400 a year before additional payments. How much do Oberärzte earn? Doctors employed at senior physician level — Oberarzt/Oberärztin — receive a higher tariff salary. The current monthly figures are: €9,459.56 from the first relevant stage €10,015.53 from the fourth year €10,810.95 from the seventh year On a 12-month basis, that is approximately: €113,515 to €129,731 per year in base salary For physicians progressing into senior hospital roles, the tariff therefore places base annual compensation comfortably above €100,000. What can the most senior doctors earn? The fourth tariff category covers physicians acting as the permanent representative of the chief physician — described as ständige Vertretung des Chefarztes, or CA-Vertreter. The salary is: €11,127.50 per month at the first published stage rising to: €11,922.95 per month at the higher stage. That equates to approximately: €133,530 to €143,075 per year in base salary These are the highest salaries included in the standard VKA physician tariff table. Is this the total amount a hospital doctor earns? Not necessarily. This is one of the most important points when interpreting the German figures. The published values are gross tariff base salaries for a full-time 40-hour working week. They do not include payments for: Bereitschaftsdienst — on-site standby/on-call duties; Rufbereitschaft — on-call availability; allowances and supplements; or other additional payments. The published guidance also states that the TV-Ärzte agreement does not include an annual special payment in these figures. As a result, a physician's actual annual gross income can be higher than the basic figures shown in the tariff table. This distinction matters when comparing German physician compensation with survey data from other countries. A salary survey reporting total earnings including overtime or additional clinical activity should not be compared directly with the German tariff base salary without understanding what is included. Does specialty affect the tariff salary? The VKA tariff does not provide separate salary scales for individual medical specialties. A cardiologist, neurologist, oncologist or radiologist employed at the same tariff grade and experience stage would generally use the same published base salary scale. Instead, compensation in this dataset is driven principally by: employment grade; specialist status; seniority; and years of relevant professional experience. The figures therefore provide a benchmark for salaried hospital physicians, rather than a measure of the earnings of individual specialties. This is an important distinction. The data should not be interpreted as showing that, for example, cardiologists earn €9,000 per month specifically because they are cardiologists. It shows what a physician employed at the relevant Facharzt or Oberarzt tariff stage is entitled to under this collective agreement. Who does the TV-Ärzte/VKA salary scale apply to? The current table applies to physicians employed in municipal hospitals covered by the TV-Ärzte/VKA agreement. It applies nationally with Berlin excluded from this particular tariff area, and the published full-time salary figures are based on a 40-hour working week. It should therefore not automatically be applied to: university hospitals operating under different collective agreements; private hospital groups with their own remuneration arrangements; physicians working primarily in private practice; self-employed doctors; or doctors whose individual employment contracts fall outside the VKA agreement. Germany has several different physician employment and remuneration structures, so understanding the employment setting is essential before using any salary benchmark. How much does experience change a specialist physician's salary? Experience makes a substantial difference within the Facharzt scale. A Facharzt at the first stage receives: €7,552.19 per month while the highest listed stage pays: €9,698.91 per month. That is an increase of approximately €2,147 per month, or nearly €25,800 per year, between the first and highest published Facharzt tariff stages. The Facharzt progression points occur from the: 1st year; 4th year; 7th year; 9th year; 11th year; and 13th year of specialist activity. For physicians assessing their compensation, it is therefore not sufficient simply to ask what a Facharzt earns. The relevant question is also: At which Facharzt experience stage am I being paid? What should hospital doctors in Germany take from the 2026 data? The 2026 VKA tariff provides a particularly clear benchmark for salaried physicians working in Germany's municipal hospital system. The major figures are: Arzt/Ärztin: €5,722–€7,355 per month Facharzt/Fachärztin: €7,552–€9,699 per month Oberarzt/Oberärztin: €9,460–€10,811 per month Permanent Chief Physician Deputy: €11,128–€11,923 per month For specialist physicians in particular, this means a published base salary of approximately: €90,600 to €116,400 per year before additional remuneration such as standby duty, on-call payments and applicable supplements. For senior Oberärzte, base salary can reach approximately: €129,700 per year and the most senior category in the standard table reaches approximately: €143,100 per year. For an individual hospital doctor, the most useful question is therefore not simply: “What do doctors earn in Germany?” It is: “What tariff group and experience stage applies to my role, and what additional payments sit on top of my contractual base salary?” That provides a much more meaningful way to benchmark physician compensation within Germany's municipal hospital system. Source: Marburger Bund / TV-Ärzte/VKA physician remuneration table, valid 1 June 2026 to 31 December 2026. Discover how nuaxia can support your next medical education initiative: Find out more about our specialist services - Moore's Outcome Assessments, Educational Needs Assessments and Patient Impact Studies for the Medical Education sector Contact us on: support@nuaxia.com

Physicians working in Health Check and Preventive Screening in Japan reported a median annual income of ¥11 million (approximately £53,000) in the latest specialty-level physician income survey from the Physician Career Research Institute. The 2025 survey, based on responses from 2,055 physicians overall, provides a useful benchmark for doctors working primarily in health checks, medical screening and preventive assessment. Among the Health Check / Preventive Screening respondents: Median annual income: ¥11 million (approximately £53,000) Proportion earning ¥20 million or more: 10.71% ¥20 million threshold: approximately £96,000 Health Check / Preventive Screening respondents: 56 Importantly, these figures include income from a physician’s main workplace as well as additional or side work. What is the median income for a Health Check or Preventive Screening physician in Japan? The reported median annual income was: ¥11 million (approximately £53,000) This represents total annual professional income including side work, rather than simply the salary paid by a physician’s main employer. A physician working primarily in preventive screening may also undertake additional clinical work or other paid medical activity. The ¥11 million figure is therefore best understood as a benchmark for total annual professional earnings. It should not be interpreted as an expected base salary. 10.71% reported earning ¥20 million or more The survey also found that: 10.71% of Health Check / Preventive Screening respondents reported annual income of ¥20 million or more (approximately £96,000+). For physicians working in this field, the two key benchmarks are therefore: Median annual income: ¥11 million (approximately £53,000) Earning ¥20 million+ (approximately £96,000+): 10.71% These figures provide a specialty-specific indication of reported professional earnings. Why does side work matter? Additional clinical work can materially affect physician income in Japan. A doctor whose main professional activity is health checking or preventive screening may also carry out other clinical sessions or paid medical work. The Physician Career Research Institute therefore reports annual income including side work. This means the ¥11 million benchmark should not be compared directly with a single employer’s salary without considering any additional professional earnings. What does the ¥11 million median actually mean? Survey participants reported income using ranges rather than exact amounts. The stated ¥11 million (approximately £53,000) median therefore represents the midpoint of the relevant income band. It should be interpreted as an approximate benchmark rather than a precise median calculated from exact earnings records. How strong is the Health Check / Preventive Screening sample? The wider survey included 2,055 physicians, with 56 respondents in Health Check / Preventive Screening. This gives the category a useful identifiable sample within the survey. However, it remains survey evidence rather than a national census of every physician working in preventive health and screening in Japan. Actual earnings may vary depending on: career stage; seniority; employer; screening centre, clinic or hospital setting; working hours; geography; additional clinical commitments; and the amount of side work undertaken. Is ¥11 million a salary? No. The clearest interpretation is: ¥11 million is the reported median total annual professional income for the Health Check / Preventive Screening physicians surveyed, including side work. It is not a published base salary. For physicians working in preventive screening, it can therefore be useful to distinguish between: salary from the principal employer; additional clinical sessions; other paid medical work; and total annual professional income. The survey benchmark relates most closely to that final figure. What should Health Check and Preventive Screening physicians take from the data? For physicians working in health checks and preventive screening in Japan, the 2025 survey provides two useful compensation benchmarks: Median annual professional income: ¥11 million (approximately £53,000) Proportion earning ¥20 million+ (approximately £96,000+): 10.71% For an individual physician, the key is to compare total professional earnings rather than salary from a single employer. The most useful question is therefore: “What is my total annual professional income as a physician working in Health Check and Preventive Screening, including additional clinical work, and how does it compare with the ¥11 million benchmark?” Source: Physician Career Research Institute / Mediwel, 2025 Physician Income Survey. Currency note: Sterling equivalents are approximate conversions using a JPY/GBP exchange rate of about £0.004797 per yen on 14 September 2026. GBP figures are included for reader context only and were not reported by the original Japanese survey. Discover how nuaxia can support your next medical education initiative: Find out more about our specialist services - Moore's Outcome Assessments, Educational Needs Assessments and Patient Impact Studies for the Medical Education sector Contact us on: support@nuaxia.com

Hematologists in Japan reported a median annual income of ¥17 million (approximately £82,000) in the latest specialty-level physician income survey from the Physician Career Research Institute. The 2025 survey, based on responses from 2,055 physicians overall, provides a specialty-specific benchmark for hematologists assessing their professional earnings in Japan. Among the Hematology respondents: Median annual income: ¥17 million (approximately £82,000) Proportion earning ¥20 million or more: 11.76% ¥20 million threshold: approximately £96,000 Hematology respondents: 17 Importantly, these figures include income from a hematologist’s main workplace as well as additional or side work. What is the median income for a hematologist in Japan? The reported median annual income for hematologists was: ¥17 million (approximately £82,000) This represents total annual professional income including side work, rather than simply salary from a hematologist’s primary hospital or employer. A hematologist may hold a principal hospital position while also undertaking additional clinical sessions or other paid professional activity. The ¥17 million figure should therefore be understood as a benchmark for total professional income. It is not an expected base salary. 11.76% of hematologists reported earning ¥20 million or more The survey also found that: 11.76% of Hematology respondents reported annual income of ¥20 million or more (approximately £96,000+). For a hematologist assessing their own compensation, the two central benchmarks are therefore: Median annual income: ¥17 million (approximately £82,000) Earning ¥20 million+ (approximately £96,000+): 11.76% These figures give hematologists a specialty-specific reference point for total professional earnings. Why does side work matter for hematologist income? Additional professional work can form an important component of physician income in Japan. Doctors may undertake work outside their principal role, including sessions at other hospitals or clinics. The Physician Career Research Institute therefore reports annual income including side work. For hematologists, this means that principal-employer salary may not represent total annual compensation. A hematologist earning below ¥17 million from their primary appointment may still reach or exceed the survey benchmark once supplementary income is included. What does the ¥17 million median actually mean? Survey participants reported their income in ranges rather than providing exact amounts. The reported median of ¥17 million (approximately £82,000) therefore represents the midpoint of the applicable income band. It should be treated as an approximate benchmark rather than a precise statistical median based on exact salary records. How strong is the Hematology sample? The wider survey contained responses from 2,055 physicians, but only 17 respondents were in Hematology. That is an important limitation. Although Hematology met the minimum threshold for specialty publication, the sample remains small. The results should therefore be treated as an indicative benchmark, not a definitive estimate for all hematologists working in Japan. Actual earnings may vary according to: career stage; seniority; employer; hospital setting; working hours; geography; additional clinical activity; and side work. Is ¥17 million a hematologist salary? No. The clearest interpretation is: ¥17 million is the reported median total annual professional income for the hematologists surveyed, including side work. It is not a published basic salary. For hematologists, the distinction between principal salary and total professional income is particularly important when making comparisons with the survey benchmark. What should hematologists take from the data? For hematologists in Japan, the 2025 survey provides two useful specialty-specific compensation markers: Median annual professional income: ¥17 million (approximately £82,000) Proportion earning ¥20 million+ (approximately £96,000+): 11.76% Because the specialty sample contains only 17 physicians, these figures should be interpreted with caution. For an individual hematologist, the most useful question is: “What is my total annual professional income as a hematologist, including additional clinical work, and how does it compare with the ¥17 million benchmark?” Source: Physician Career Research Institute / Mediwel, 2025 Physician Income Survey. Currency note: Sterling equivalents are approximate conversions using a JPY/GBP exchange rate of about £0.004797 per yen on 14 September 2026. GBP figures are included for reader context only and were not reported by the original Japanese survey. Discover how nuaxia can support your next medical education initiative: Find out more about our specialist services - Moore's Outcome Assessments, Educational Needs Assessments and Patient Impact Studies for the Medical Education sector Contact us on: support@nuaxia.com

Breast surgeons in Japan reported a median annual income of ¥13 million (approximately £62,000) in the latest specialty-level physician income survey from the Physician Career Research Institute. The 2025 survey, based on responses from 2,055 physicians overall, provides a specialty-specific benchmark for breast surgeons assessing their professional earnings in Japan. Among the Breast Surgery respondents: Median annual income: ¥13 million (approximately £62,000) Proportion earning ¥20 million or more: 12.50% ¥20 million threshold: approximately £96,000 Breast Surgery respondents: 16 Importantly, the reported income includes earnings from a breast surgeon’s main workplace as well as additional or side work. What is the median income for a breast surgeon in Japan? The reported median annual income for breast surgeons was: ¥13 million (approximately £62,000) This represents total annual professional income including side work, not simply salary from a surgeon’s primary hospital or employer. A breast surgeon may hold a principal hospital appointment while also carrying out additional clinical sessions or other paid medical work. The ¥13 million figure is therefore best interpreted as a benchmark for total annual professional earnings. It should not be treated as an expected base salary. 12.50% of breast surgeons reported earning ¥20 million or more The survey also found that: 12.50% of Breast Surgery respondents reported annual income of ¥20 million or more (approximately £96,000+). That is one in eight of the breast surgeons included in this specialty sample. For a breast surgeon assessing their own position, the two main benchmarks are: Median annual income: ¥13 million (approximately £62,000) Earning ¥20 million+ (approximately £96,000+): 12.50% Why does side work matter for breast surgeon income? Additional professional work can contribute materially to physician earnings in Japan. Doctors may undertake work outside their main appointment, including clinical sessions at other hospitals or clinics. The Physician Career Research Institute therefore reports annual income including side work. For breast surgeons, salary from the primary employer may consequently be only one part of total professional earnings. A surgeon earning less than ¥13 million from their principal role could still reach the survey benchmark when additional clinical income is included. What does the ¥13 million median actually mean? Survey respondents reported income using ranges rather than exact figures. The reported ¥13 million (approximately £62,000) median is therefore based on the midpoint of the relevant income band. It should be treated as an approximate benchmark rather than an exact statistical median derived from individual payroll records. How strong is the Breast Surgery sample? The wider research included 2,055 physicians, but only 16 respondents were in Breast Surgery. That is a significant limitation. The specialty only just exceeded the survey’s minimum threshold of 15 respondents for publication. The finding is therefore useful as an indication of reported breast surgeon income, but it should not be treated as a definitive national estimate. Actual earnings can vary with: seniority; career stage; hospital or clinical setting; working hours; geography; clinical workload; additional professional activity; and side work. Is ¥13 million a breast surgeon salary? No. The clearest interpretation is: ¥13 million is the reported median total annual professional income for the breast surgeons surveyed, including side work. It is not a published base salary. For breast surgeons reviewing their own compensation, it is useful to distinguish between: principal employer salary; additional paid clinical activity; other professional income; and total annual earnings. The survey benchmark relates most closely to total annual earnings. What should breast surgeons take from the data? For breast surgeons in Japan, the latest specialty data provides two useful reference points: Median annual professional income: ¥13 million (approximately £62,000) Proportion earning ¥20 million+ (approximately £96,000+): 12.50% Because the sample is only 16 physicians, the figures should be used cautiously. For an individual breast surgeon, the more useful question is: “What is my total annual professional income as a breast surgeon, including additional clinical work, and how does it compare with the ¥13 million benchmark?” Source: Physician Career Research Institute / Mediwel, 2025 Physician Income Survey. Currency note: Sterling equivalents are approximate conversions using a JPY/GBP exchange rate of about £0.004797 per yen on 14 September 2026. GBP figures are included for reader context only and were not reported by the original Japanese survey. Discover how nuaxia can support your next medical education initiative: Find out more about our specialist services - Moore's Outcome Assessments, Educational Needs Assessments and Patient Impact Studies for the Medical Education sector Contact us on: support@nuaxia.com

Physical Medicine & Rehabilitation physicians in Japan reported a median annual income of ¥15 million (approximately £72,000) in the latest specialty-level physician income survey from the Physician Career Research Institute. The 2025 survey, based on responses from 2,055 physicians overall, provides a useful benchmark for physicians working in Physical Medicine & Rehabilitation who are assessing their professional earnings in Japan. Among the Physical Medicine & Rehabilitation respondents: Median annual income: ¥15 million (approximately £72,000) Proportion earning ¥20 million or more: 14.29% ¥20 million threshold: approximately £96,000 Physical Medicine & Rehabilitation respondents: 28 Importantly, these figures include income from a physician’s main workplace as well as additional or side work. For Physical Medicine & Rehabilitation physicians looking at their own compensation, that distinction is essential. What is the median income for a Physical Medicine & Rehabilitation physician in Japan? The reported median annual income was: ¥15 million (approximately £72,000) This represents total annual professional income including side work, rather than simply the salary paid by a physician’s principal hospital, rehabilitation facility, clinic or other employer. Physicians in Japan may receive income from more than one professional role. A rehabilitation physician may hold a primary position while also undertaking additional clinical sessions or other paid medical work. The ¥15 million figure is therefore best understood as a benchmark for total annual professional earnings. It should not be interpreted as an expected base salary. 14.29% reported earning ¥20 million or more The survey provides another useful benchmark for Physical Medicine & Rehabilitation physicians. 14.29% of respondents reported annual income of ¥20 million or more (approximately £96,000+). That means roughly one in seven physicians in this specialty sample reported total annual professional earnings at or above this level. The two central benchmarks are therefore: Median annual income: ¥15 million (approximately £72,000) Earning ¥20 million+ (approximately £96,000+): 14.29% Why does side work matter? Additional professional work can form an important part of physician earnings in Japan. Doctors may undertake paid activity outside their main appointment, including sessions at other hospitals, clinics or rehabilitation settings. The Physician Career Research Institute therefore reports annual income including side work. For Physical Medicine & Rehabilitation physicians, this means that salary from the principal employer may not represent total annual earnings. A physician whose main salary is below ¥15 million could still reach or exceed the survey benchmark once additional professional income is included. Equally, the figure should not be interpreted as a ¥15 million basic salary from a single employer. What does the ¥15 million median actually mean? Survey participants reported income in ranges rather than providing exact annual amounts. The reported median of ¥15 million (approximately £72,000) therefore represents the midpoint of the relevant income band. It should be treated as an approximate compensation benchmark rather than a precise mathematical median calculated from exact payroll data. How strong is the Physical Medicine & Rehabilitation sample? The wider survey included 2,055 physicians, with 28 respondents in Physical Medicine & Rehabilitation. That is a relatively small specialty sample. The research only published specialty-level findings where at least 15 physicians responded, so the specialty met the publication threshold, but the result should still be interpreted with appropriate caution. Actual earnings may vary depending on: career stage; seniority; employer; hospital or rehabilitation setting; working hours; geographic location; additional clinical commitments; and the amount of side work undertaken. Is ¥15 million a base salary? No. The clearest interpretation is: ¥15 million is the reported median total annual professional income for the Physical Medicine & Rehabilitation physicians surveyed, including side work. It is not a published base salary. For a physician assessing their compensation, it is useful to distinguish between: guaranteed income from the principal employer; additional paid clinical sessions; other professional income; and total annual earnings. The survey benchmark relates most closely to that final figure. What should Physical Medicine & Rehabilitation physicians take from the data? For physicians working in Physical Medicine & Rehabilitation in Japan, the 2025 survey provides two useful benchmarks. Median annual professional income, including side work, was: ¥15 million (approximately £72,000) And: 14.29% reported earning ¥20 million or more (approximately £96,000+). The key is to compare like with like. For an individual physician, the most useful question is: “What is my total annual professional income as a Physical Medicine & Rehabilitation physician, including additional clinical work, and how does it compare with the ¥15 million benchmark?” Source: Physician Career Research Institute / Mediwel, 2025 Physician Income Survey. Currency note: Sterling equivalents are approximate conversions using a JPY/GBP exchange rate of about £0.004797 per yen on 14 September 2026. GBP figures are included for reader context only and were not reported by the original Japanese survey. Discover how nuaxia can support your next medical education initiative: Find out more about our specialist services - Moore's Outcome Assessments, Educational Needs Assessments and Patient Impact Studies for the Medical Education sector Contact us on: support@nuaxia.com

Pathologists in Japan reported a median annual income of ¥15 million (approximately £72,000) in the latest specialty-level physician income survey from the Physician Career Research Institute. The 2025 survey, based on responses from 2,055 physicians overall, provides a useful benchmark for pathologists assessing their professional earnings in Japan. Among the Pathology respondents: Median annual income: ¥15 million (approximately £72,000) Proportion earning ¥20 million or more: 15.79% ¥20 million threshold: approximately £96,000 Pathology respondents: 19 Importantly, these figures include income from a pathologist’s main workplace as well as additional or side work. For pathologists looking at their own compensation, that distinction is essential. What is the median income for a pathologist in Japan? The reported median annual income for pathologists was: ¥15 million (approximately £72,000) This represents total annual professional income including side work, rather than simply the salary paid by a pathologist’s principal hospital, laboratory or other employer. That matters because physicians in Japan may receive income from more than one professional role. A pathologist may hold a primary hospital or laboratory position while also undertaking additional diagnostic, clinical or other paid medical work. The ¥15 million figure is therefore best understood as a benchmark for total annual professional earnings. It should not be interpreted as an expected base salary. 15.79% of pathologists reported earning ¥20 million or more The survey provides another useful benchmark for pathologists. 15.79% of Pathology respondents reported annual income of ¥20 million or more (approximately £96,000+). That means around one in six pathologists included in the survey reported total annual professional earnings at or above this level. For a pathologist assessing their own compensation, the two central figures are therefore: Median annual income: ¥15 million (approximately £72,000) Earning ¥20 million+ (approximately £96,000+): 15.79% Together, these figures provide a useful indication of the income levels reported within Pathology. Why does side work matter for pathologist income? Additional professional work can form an important part of physician earnings in Japan. Doctors may undertake paid work outside their main position, including work for other hospitals, laboratories, clinics or other medical organisations. The Physician Career Research Institute therefore reports annual income including side work. For pathologists, this means that salary from the principal employer may not represent total annual earnings. A pathologist whose main salary is below ¥15 million could still reach or exceed the survey benchmark when supplementary professional income is included. Equally, the survey should not be interpreted as showing that pathologists should expect a ¥15 million basic salary from a single employer. The figure represents a broader measure of total professional income. What does the ¥15 million median actually mean? There is an important methodological point behind the headline figure. Survey participants reported income in ranges rather than providing an exact annual amount. The reported median of ¥15 million (approximately £72,000) therefore represents the midpoint of the relevant income band. It should be treated as an approximate compensation benchmark rather than a precise mathematical median calculated from exact salary records. For a pathologist reviewing their own income, the figure is most useful as a broad reference point for total annual professional earnings. How strong is the Pathology sample? The wider survey included 2,055 physicians, with 19 respondents in Pathology. That is an important limitation. The research only published specialty-level figures for groups with at least 15 respondents, so Pathology met the threshold for inclusion. However, 19 physicians remains a small sample. The findings should therefore be treated as a useful specialty benchmark rather than a definitive national estimate for every pathologist working in Japan. Actual earnings may vary depending on factors such as: career stage; seniority; employer; hospital or laboratory setting; working hours; geographic location; additional diagnostic or professional commitments; and the amount of side work undertaken. Is ¥15 million a pathologist salary? No. The clearest interpretation is: ¥15 million is the reported median total annual professional income for the pathologists surveyed, including side work. It is not a published base salary. For a pathologist considering a new role or assessing existing compensation, it can therefore be useful to distinguish between: guaranteed income from the principal employer; additional paid diagnostic or clinical work; other professional income; and total annual earnings. The survey benchmark relates most closely to that final figure. What should pathologists take from the latest data? For pathologists in Japan, the 2025 survey provides two particularly useful compensation benchmarks. Median annual professional income, including side work, was: ¥15 million (approximately £72,000) And: 15.79% of pathologists reported earning ¥20 million or more (approximately £96,000+). For an individual pathologist, these figures provide a useful reference point when considering total annual professional earnings. The important point is to compare like with like. A salary from a single hospital or laboratory should not be compared directly with a survey figure that incorporates additional professional work. For pathologists, the more useful question is therefore not simply: “What is a pathologist’s salary in Japan?” It is: “What is my total annual professional income as a pathologist, including additional professional work, and how does it compare with the ¥15 million benchmark?” That is the most meaningful way to use the available Pathology compensation data. Source: Physician Career Research Institute / Mediwel, 2025 Physician Income Survey. Currency note: Sterling equivalents are approximate conversions using the JPY/GBP exchange rate on 14 September 2026. At that rate, ¥15 million is approximately £72,000 and ¥20 million approximately £96,000. GBP figures are included for reader context only and were not reported by the original Japanese survey. Discover how nuaxia can support your next medical education initiative: Find out more about our specialist services - Moore's Outcome Assessments, Educational Needs Assessments and Patient Impact Studies for the Medical Education sector Contact us on: support@nuaxia.com

Gynecologists in Japan reported a median annual income of ¥13 million (approximately £62,000) in the latest specialty-level physician income survey from the Physician Career Research Institute. The 2025 survey, based on responses from 2,055 physicians overall, provides a useful benchmark for gynecologists assessing their professional earnings in Japan. Among the Gynecology respondents: Median annual income: ¥13 million (approximately £62,000) Proportion earning ¥20 million or more: 16.67% ¥20 million threshold: approximately £96,000 Gynecology respondents: 24 Importantly, these figures include income from a gynecologist’s main workplace as well as additional or side work. For gynecologists looking at their own compensation, that distinction is essential. What is the median income for a gynecologist in Japan? The reported median annual income for gynecologists was: ¥13 million (approximately £62,000) This represents total annual professional income including side work, rather than simply the salary paid by a gynecologist’s principal hospital, clinic or other employer. That matters because physicians in Japan may receive income from more than one professional role. A gynecologist may hold a primary hospital or clinic position while also undertaking additional clinical sessions or other paid medical work. The ¥13 million figure is therefore best understood as a benchmark for total annual professional earnings. It should not be interpreted as an expected base salary. 16.67% of gynecologists reported earning ¥20 million or more The survey provides another useful benchmark for gynecologists. 16.67% of Gynecology respondents reported annual income of ¥20 million or more (approximately £96,000+). That means roughly one in six gynecologists included in the survey reported total annual professional earnings at or above this level. For a gynecologist assessing their own compensation, the two central figures are therefore: Median annual income: ¥13 million (approximately £62,000) Earning ¥20 million+ (approximately £96,000+): 16.67% Together, these figures provide a useful indication of the income levels reported within Gynecology. Why does side work matter for gynecologist income? Additional professional work can form an important part of physician earnings in Japan. Doctors may undertake paid work outside their main position, including sessions at other hospitals or clinics and other secondary medical activity. The Physician Career Research Institute therefore reports annual income including side work. For gynecologists, this means that salary from the principal employer may not represent total annual earnings. A gynecologist whose main salary is below ¥13 million could still reach or exceed the survey benchmark when supplementary clinical income is included. Equally, the survey should not be interpreted as showing that gynecologists should expect a ¥13 million basic salary from a single employer. The figure represents a broader measure of total professional income. What does the ¥13 million median actually mean? There is an important methodological point behind the headline figure. Survey participants reported income in ranges rather than providing an exact annual amount. The reported median of ¥13 million (approximately £62,000) therefore represents the midpoint of the relevant income band. It should be treated as an approximate compensation benchmark rather than a precise mathematical median calculated from exact salary records. For a gynecologist reviewing their own income, the figure is most useful as a broad reference point for total annual professional earnings. How strong is the Gynecology sample? The wider survey included 2,055 physicians, with 24 respondents in Gynecology. That is an important limitation. The research only published specialty-level figures for groups with at least 15 respondents, so Gynecology met the threshold for inclusion. However, 24 physicians remain a relatively small sample. The findings should therefore be treated as a useful specialty benchmark rather than a definitive national estimate for every gynecologist working in Japan. Actual earnings may vary depending on factors such as: career stage; seniority; employer; hospital or clinic setting; working hours; geographic location; additional clinical commitments; and the amount of side work undertaken. Is ¥13 million a gynecologist salary? No. The clearest interpretation is: ¥13 million is the reported median total annual professional income for the gynecologists surveyed, including side work. It is not a published base salary. For a gynecologist considering a new role or assessing existing compensation, it can therefore be useful to distinguish between: guaranteed income from the principal employer; additional paid clinical sessions; other professional income; and total annual earnings. The survey benchmark relates most closely to that final figure. What should gynecologists take from the latest data? For gynecologists in Japan, the 2025 survey provides two particularly useful compensation benchmarks. Median annual professional income, including side work, was: ¥13 million (approximately £62,000) And: 16.67% of gynecologists reported earning ¥20 million or more (approximately £96,000+). For an individual gynecologist, these figures provide a useful reference point when considering total annual professional earnings. The important point is to compare like with like. A salary from a single hospital or clinic should not be compared directly with a survey figure that incorporates additional professional work. For gynecologists, the more useful question is therefore not simply: “What is a gynecologist’s salary in Japan?” It is: “What is my total annual professional income as a gynecologist, including additional clinical work, and how does it compare with the ¥13 million benchmark?” That is the most meaningful way to use the available Gynecology compensation data. Source: Physician Career Research Institute / Mediwel, 2025 Physician Income Survey. Currency note: Sterling equivalents are approximate conversions using the JPY/GBP exchange rate on 14 September 2026. At that rate, ¥13 million is approximately £62,000 and ¥20 million approximately £96,000. GBP figures are included for reader context only and were not reported by the original Japanese survey. Discover how nuaxia can support your next medical education initiative: Find out more about our specialist services - Moore's Outcome Assessments, Educational Needs Assessments and Patient Impact Studies for the Medical Education sector Contact us on: support@nuaxia.com